Intergroupe Francophone de Cancerologie Thoracique
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 2 interventional trial registration with no results posted; it describes a planned study of personalized immunotherapy selection based on MRD detection in stage III NSCLC, addressing an important clinical question but carrying no outcome data.
This is a Phase 2 trial registration with no reported results; the study is active but not yet recruiting, so efficacy and safety data are not yet available for clinical assessment.